Table 3.
Variables | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. TPV | − | |||||||||||||
2. PZT | –0.21** | − | ||||||||||||
3. CGL | 0.90*** | −0.32*** | − | |||||||||||
4. CGW | 0.85*** | –0.33*** | 0.86*** | − | ||||||||||
5. CGH | 0.86*** | −0.29*** | 0.82*** | 0.82*** | − | |||||||||
6. CGV | 0.96*** | −0.31*** | 0.89*** | 0.87*** | 0.88*** | − | ||||||||
7. TGL | 0.89*** | −0.14* | 0.93*** | 0.79*** | 0.78*** | 0.83*** | − | |||||||
8. TGW | 0.81*** | −0.05 | 0.73*** | 0.80*** | 0.69*** | 0.73*** | 0.67*** | − | ||||||
9. TGH | 0.89*** | −0.29*** | 0.82*** | 0.78*** | 0.90*** | 0.83*** | 0.78*** | 0.71*** | − | |||||
10. PZV | 0.58*** | 0.16* | 0.45*** | 0.34*** | 0.36*** | 0.33*** | 0.56*** | 0.61*** | 0.60*** | − | ||||
11. ACT | 0.02 | 0.11 | −0.01 | −0.01 | −0.01 | 0.02 | 0.04 | 0.04 | 0.04 | 0.10 | − | |||
12. Age | 0.35*** | −0.2035** | 0.42*** | 0.42*** | 0.35*** | 0.32*** | 0.40*** | 0.40*** | 0.31*** | 0.24** | 0.06 | − | ||
13. BMI | 0.09 | 0.00 | 0.09 | 0.01 | 0.06 | 0.03 | 0.10 | 0.06 | 0.13 | 0.17 | 0.15 | 0.03 | − | |
14. PSA | 0.02 | 0.00 | 0.01 | −0.03 | −0.05 | 0.03 | 0.01 | −0.08 | −0.02 | −0.02 | −0.04 | 0.20 | −0.29 | − |
Variables | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 |
M | 43.48 | 7.82 | 2.91 | 3.68 | 3.33 | 24.42 | 3.62 | 4.95 | 4.13 | 19.06 | 1.04 | 61.57 | 29.05 | 10.35 |
SD | 32.46 | 2.31 | 0.98 | 1.23 | 1.13 | 27.90 | 0.98 | 0.90 | 1.06 | 9.77 | 0.16 | 13.90 | 6.26 | 17.97 |
Correlations (N = 204).
p < 0.05, **p < 0.01, ***p < 0.001.
ACT, average capsule thickness; BMI, body mass index; CGH, central gland height; CGL, central gland length; CGV, central gland volume; CGW, central gland width; M, Mean; PSA, prostate-specific antigen; PZT, peripheral zone thickness; PZV, peripheral zone volume; SD, standard deviation; TGH, total gland height; TGL, total gland length; TGW, total gland width; TPV, total prostate volume.